合成路线1
该中间体在本合成路线中的序号:
(XIX) 3) The reaction of diethyl malonate (XVIII) with 3-methylbutanal (XIX) by means of dipropylamine in acetic acid gives the corresponding 2-(3-methylbutylidene)malonate derivative (XX), which is treated with KCN to yield the corresponding addition compound (XXI). The decarboxylative hydrolysis of (XXI) with KOH affords 3-cyano-5-methylhexanoic acid (XXII), which is reduced with H2 over Ni to yield racemic pregabalin (XXIII). Finally, this racemate is submitted to optical resolution with (S)-(+)-mandelic acid.
【1】
Bryans, J.S.; Wustrow, D.J.; 3-Substituted GABA analogs with central nervous system activity: A review. Med Res Rev 1999, 19, 2, 149.
|
【2】
Newhouse, B.J.; Ibrahim, P.; Burgess, L.E.; et al.; Potent selective nonpeptidic inhibitors of human lung tryptase. Proc Natl Acad Sci USA 1999, 96, 15, 8348.
|
【3】
Mulhern, T.; Sobieray, D.M.; Huckabee, B.K.; Grote, T.M.; Titus, R.D. (Pfizer Inc.); Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid. WO 9640617 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XVIII) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XIX) |
26052 |
3-methylbutanal
|
590-86-3 |
C5H10O |
详情 | 详情
|
(XX) |
26053 |
diethyl 2-(3-methylbutylidene)malonate
|
|
C12H20O4 |
详情 |
详情
|
(XXI) |
26054 |
diethyl 2-(1-cyano-3-methylbutyl)malonate
|
|
C13H21NO4 |
详情 |
详情
|
(XXII) |
26055 |
3-cyano-5-methylhexanoic acid
|
|
C8H13NO2 |
详情 |
详情
|
(XXIII) |
26056 |
3-(aminomethyl)-5-methylhexanoic acid
|
130912-52-6 |
C8H17NO2 |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(XIX) 5) The condensation of 3-methylbutanal (XIX) with cyanoacetic acid ethyl ester (XXXII) or cyanoacetamide (XXXIII) by means of dipropylamine in refluxing hexane, followed by treatment with refluxing 6N HCl, gives 3-isobutylglutaric acid (XXXIV). This compound is converted into the corresponding anhydride (XXXV) by treatment with refluxing acetic anhydride. The reaction of the anhydride (XXXV) with NH4OH affords the glutaramic amide (XXXVI), which is submitted to optical resolution with (R)-(+)-1-phenylethylamine, yielding the (S)-enantiomer (XXXVII). Finally, this compound is submitted to a Hoffmann degradation with Br2/NaOH.
【1】
Newhouse, B.J.; Ibrahim, P.; Burgess, L.E.; et al.; Potent selective nonpeptidic inhibitors of human lung tryptase. Proc Natl Acad Sci USA 1999, 96, 15, 8348.
|
【2】
Sobieray, D.M.; Hoekstra, M.S.; Schwindt, M.A.; et al.; Chemical development of CI-1008, an enantiomerically pure anticonvulsant. Org Process Res Dev 1997, 1, 1, 26.
|
【3】
Huckabee, B.K.; Sobieray, D.M. (Pfizer Inc.); Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid. WO 9638405 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIX) |
26052 |
3-methylbutanal
|
590-86-3 |
C5H10O |
详情 | 详情
|
(XXXII) |
11877 |
Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate
|
105-56-6 |
C5H7NO2 |
详情 | 详情
|
(XXXIII) |
12122 |
Cyanoacetamide; 2-Cyanoacetamide
|
107-91-5 |
C3H4N2O |
详情 | 详情
|
(XXXIV) |
26065 |
3-isobutylpentanedioic acid
|
|
C9H16O4 |
详情 |
详情
|
(XXXV) |
26066 |
4-isobutyldihydro-2H-pyran-2,6(3H)-dione
|
|
C9H14O3 |
详情 |
详情
|
(XXXVI) |
26067 |
3-(2-amino-2-oxoethyl)-5-methylhexanoic acid
|
|
C9H17NO3 |
详情 |
详情
|
(XXXVII) |
26068 |
(3R)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid
|
|
C9H17NO3 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) Cyclization of 2,2-dichloroisobutyraldehyde (I) - obtained by reaction of isovaleraldehyde (II) with chlorine in DMF - with 2-benzyloxyacetaldehyde (III) - produced by reaction of 2-butene-1,4-diol (IV) with benzyl chloride by means of NaOH in water, followed by ozonolysis in MeOH and finally reduction with triphenylphosphine in ethyl acetate - and aqueous NH4OH in methanol gives the imidazole derivative (VI), which is iodinated with I2 and NaOH in dichloromethane to yield the 5-iodoimidaz-ole derivative (VII). Condensation of compound (VII) with bis(3,5-dichlorophenyl)disulfide (VIII) by means of LiH in DMSO affords the dichlorophenylsulfanyl imidazole (IX), which is alkylated with 4-(chloromethyl)pyridine (X) and K2CO3 in DMF to provide the fully substituted imidazole (XI). Debenzylation of compound (XI) with conc. HCl in refluxing ethanol gives the carbinol (XII), which is finally treated with trichloroacetyl isocyanate and triethylamine in methanol/water.
【1】
Sorbera, L.A.; Castañer, J.; Bayes, M.; Capravirine. Drugs Fut 2003, 28, 12, 1149.
|
【2】
Sugita, K.; Makino, I.; Sugimoto, H.; et al.; Synthesis and biological activity of imidazole derivatives as a novel class of HIV-1 nonnucleoside reverse transcriptase inhibitors. Symp Med Chem 1999, Abst 2P-05.
|
【3】
Aono, K.; Ichihashi, T.; Sugawara, T.; Hirano, K. (Shionogi & Co. Ltd.); Lymph-absorbable imidazole derivs.. EP 0893442; US 6054591; WO 9735843 .
|
【4】
Sugimoto, H.; Fujiwara, T. (Shionogi & Co. Ltd.); Imidazole deriv.. EP 0786455; US 5910506; US 6147097; WO 9610019 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
40725 |
2,2,2-trichloroacetyl isocyanate
|
3019-71-4 |
C3Cl3NO2 |
详情 | 详情
|
(I) |
35840 |
2,2-dichloro-3-methylbutanal
|
|
C5H8Cl2O |
详情 |
详情
|
(II) |
26052 |
3-methylbutanal
|
590-86-3 |
C5H10O |
详情 | 详情
|
(III) |
17346 |
Benzyloxyacetaldehyde; 2-(Benzyloxy)acetaldehyde
|
60656-87-3 |
C9H10O2 |
详情 | 详情
|
(IV) |
36995 |
4-[2-(1-piperidinyl)ethoxy]benzoyl chloride
|
|
C14H18ClNO2 |
详情 |
详情
|
(V) |
63296 |
1-({[(Z)-4-(benzyloxy)-2-butenyl]oxy}methyl)benzene; benzyl (Z)-4-(benzyloxy)-2-butenyl ether
|
|
C18H20O2 |
详情 |
详情
|
(VI) |
35841 |
benzyl (4-isopropyl-1H-imidazol-2-yl)methyl ether; 2-[(benzyloxy)methyl]-4-isopropyl-1H-imidazole
|
|
C14H18N2O |
详情 |
详情
|
(VII) |
35842 |
2-[(benzyloxy)methyl]-5-iodo-4-isopropyl-1H-imidazole; benzyl (5-iodo-4-isopropyl-1H-imidazol-2-yl)methyl ether
|
|
C14H17IN2O |
详情 |
详情
|
(VIII) |
35843 |
bis(3,5-dichlorophenyl) disulfide; 1,3-dichloro-5-[(3,5-dichlorophenyl)disulfanyl]benzene
|
137897-99-5 |
C12H6Cl4S2 |
详情 | 详情
|
(IX) |
35844 |
benzyl [5-[(3,5-dichlorophenyl)sulfanyl]-4-isopropyl-1H-imidazol-2-yl]methyl ether; 2-[(benzyloxy)methyl]-5-[(3,5-dichlorophenyl)sulfanyl]-4-isopropyl-1H-imidazole
|
|
C20H20Cl2N2OS |
详情 |
详情
|
(X) |
10844 |
4-(Chloromethyl)pyridine
|
10445-91-7 |
C6H6ClN |
详情 | 详情
|
(XI) |
35845 |
4-([2-[(benzyloxy)methyl]-5-[(3,5-dichlorophenyl)sulfanyl]-4-isopropyl-1H-imidazol-1-yl]methyl)pyridine; benzyl [5-[(3,5-dichlorophenyl)sulfanyl]-4-isopropyl-1-(4-pyridinylmethyl)-1H-imidazol-2-yl]methyl ether
|
|
C26H25Cl2N3OS |
详情 |
详情
|
(XII) |
35846 |
[5-[(3,5-dichlorophenyl)sulfanyl]-4-isopropyl-1-(4-pyridinylmethyl)-1H-imidazol-2-yl]methanol
|
|
C19H19Cl2N3OS |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(III) Hydrogenation of 6-methylpyridine-2-carboxylic acid (I) over Pd/C in aqueous ammonia afforded the corresponding piperidine (II). Subsequent condensation of (II) with isovaleraldehyde (III), followed by catalytic hydrogenation with Pd/C provided the N-isopentyl piperidine (IV), which was finally coupled with O-benzyltyrosine tert-butyl ester (V) in the presence of benzotriazolyl tetramethyluronium hexafluorophosphate (HBTU) to furnish the target amide.
【1】
Szoke, B.G.; Hu, L.-Y.; Millerman, E.; Nikam, S.S.; Rafferty, M.F.; Ryder, T.R.; Synthesis and biological evaluation of substituted 4-(OBz)phenylalanine derivatives as novel N-type calcium channel blockers. Bioorg Med Chem Lett 1999, 9, 8, 1121.
|
【2】
Hu, L.-Y.; et al.; PD 151307 analogs: Synthesis and biological evaluation of substituted 4-(OBz)phenylalanine derivatives as novel N-type calcium channel blockers. 217th ACS Natl Meet (March 21 1999, Anaheim) 1999, Abst MEDI 119.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30380 |
6-methyl-2-pyridinecarboxylic acid
|
934-60-1 |
C7H7NO2 |
详情 | 详情
|
(II) |
30381 |
6-methyl-2-piperidinecarboxylic acid
|
|
C7H13NO2 |
详情 |
详情
|
(III) |
26052 |
3-methylbutanal
|
590-86-3 |
C5H10O |
详情 | 详情
|
(IV) |
30382 |
1-isopentyl-6-methyl-2-piperidinecarboxylic acid
|
|
C12H23NO2 |
详情 |
详情
|
(V) |
26717 |
tert-butyl (2S)-2-amino-3-[4-(benzyloxy)phenyl]propanoate
|
|
C20H25NO3 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(XIII) Piperazine-2-carboxylic acid (VIII) was prepared by catalytic hydrogenation of pyrazine (VII). Sequential protection of the N-4 of (VIII) with 2-(t-butoxycarbonyloxyimino)-2-phenylacetonitrile and the N-1 with benzyl chloroformate provided the diprotected piperazinecarboxylic acid (X), which was subsequently esterified with diazomethane to give the methyl ester (XI). The N-benzyloxycarbonyl group of (XI) was selectively deprotected by hydrogenation in the presence of Pd/C to yield the N-Boc-piperazine (XII). Reductive alkylation of (XII) with isovaleraldehyde (XIII) afforded the corresponding N-isoamyl piperazine (XIV). After acid removal of the N-Boc group of (XIV) to yield (XV), a second reductive alkylation with acetone (XVI) produced the dialkyl piperazine (XVII). Hydrolysis of the methyl ester group of (XVII) under acidic conditions gave acid (XVIII). This was finally coupled with the intermediate piperidine (VI) in the presence of HBTU to provide the title compound.
【1】
Rafferty, M.F.; Hu, L.-Y.; Ryder, T.R.; et al.; Synthesis and biological activity of 4-aminopiperidine derivatives as N-type calcium channel antagonists. Med Chem Res 2000, 10, 1, 11.
|
【2】
Ryder, T.R.; Rafferty, M.F.; Hu, L.-Y. (Pfizer Inc.); Heterocyclic substd. aniline calcium channel blockers. US 6251919; WO 9943658 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
38232 |
N-[4-(benzyloxy)phenyl]-N-(3-methyl-2-butenyl)-N-(4-piperidinyl)amine; N-[4-(benzyloxy)phenyl]-N-(3-methyl-2-butenyl)-4-piperidinamine
|
|
C23H30N2O |
详情 |
详情
|
(VII) |
37256 |
2-pyrazinecarboxylic acid; Pyrazinoic acid
|
98-97-5 |
C5H4N2O2 |
详情 | 详情
|
(VIII) |
25933 |
2-piperazinecarboxylic acid; Piperazine-2-carboxylic acid
|
|
C5H10N2O2 |
详情 |
详情
|
(IX) |
25934 |
4-(tert-butoxycarbonyl)-2-piperazinecarboxylic acid
|
|
C10H18N2O4 |
详情 |
详情
|
(X) |
48403 |
N-4-Boc-N-1-CBz-2-piperazinecarboxylic acid; 1-[(benzyloxy)carbonyl]-4-(tert-butoxycarbonyl)-2-piperazinecarboxylic acid
|
129365-23-7 |
C18H24N2O6 |
详情 | 详情
|
(XI) |
48404 |
1-benzyl 4-(tert-butyl) 2-methyl 1,2,4-piperazinetricarboxylate
|
|
C19H26N2O6 |
详情 |
详情
|
(XII) |
48405 |
1-(tert-butyl) 3-methyl 1,3-piperazinedicarboxylate
|
|
C11H20N2O4 |
详情 |
详情
|
(XIII) |
26052 |
3-methylbutanal
|
590-86-3 |
C5H10O |
详情 | 详情
|
(XIV) |
48406 |
1-(tert-butyl) 3-methyl 4-isopentyl-1,3-piperazinedicarboxylate
|
|
C16H30N2O4 |
详情 |
详情
|
(XV) |
48407 |
methyl 1-isopentyl-2-piperazinecarboxylate
|
|
C11H22N2O2 |
详情 |
详情
|
(XVI) |
23199 |
2-Propanone; Acetone; beta-ketopropane; chevron acetone;propan-2-one; Dimethyl formaldehyde; Dimethyl ketone; dimethylketal; Ketone propane; Methyl ketone; Propanone; Pyroacetic acid; Pyroacetic ether |
67-64-1 |
C3H6O |
详情 | 详情
|
(XVII) |
48408 |
methyl 1-isopentyl-4-isopropyl-2-piperazinecarboxylate
|
|
C14H28N2O2 |
详情 |
详情
|
(XVIII) |
48409 |
1-isopentyl-4-isopropyl-2-piperazinecarboxylic acid
|
|
C13H26N2O2 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(III) The condensation of tert-butoxycarbonylproline (I) with methylamine (II), isovaleraldehyde (III) and ethyl isocyanoacetate (IV) in methanol gives Boc-Pro-Me-Leu-Gly-OEt (V), which is separated from its diastereoisomer by chromatography over silica gel. The reaction of (V) with ammonia in cold methanol yields the corresponding amide (VI). Finally this compound is deprotected by treatment with dry HCl in ethyl acetate
【1】
Blancafort, P.; Serradell, M.N.; Castaner, J.; Owen, R.T.; Pareptide. Drugs Fut 1979, 4, 11, 821.
|
【2】
Failli, A.; et al.; Synthetic MIF analoges. Part I:synthesis by four component condensation (4CC) and classical methods. Arzneim-Forsch 1977, 27, 12, 2286.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16734 |
(2S)-1-(tert-butoxycarbonyl)tetrahydro-1H-pyrrole-2-carboxylic acid; N-alpha-t-BOC-L-proline; (2S)-1-(tert-butoxycarbonyl)-2-pyrrolidinecarboxylic acid
|
|
C10H17NO4 |
详情 |
详情
|
(II) |
11021 |
Methanamine; Methylamine
|
74-89-5 |
CH5N |
详情 | 详情
|
(III) |
26052 |
3-methylbutanal
|
590-86-3 |
C5H10O |
详情 | 详情
|
(IV) |
11877 |
Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate
|
105-56-6 |
C5H7NO2 |
详情 | 详情
|
(V) |
60946 |
tert-butyl (2S)-2-{[((1R)-1-{[(2-ethoxy-2-oxoethyl)amino]carbonyl}-3-methylbutyl)(methyl)amino]carbonyl}-1-pyrrolidinecarboxylate
|
|
C21H37N3O6 |
详情 |
详情
|
(VI) |
60947 |
tert-butyl (2S)-2-{[((1R)-1-{[(2-amino-2-oxoethyl)amino]carbonyl}-3-methylbutyl)(methyl)amino]carbonyl}-1-pyrrolidinecarboxylate
|
|
C19H34N4O5 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(II)
【1】
Zhang GS, Yang XP, Ma, YQ, et aL. 2006. Method for preparation of Pregabalin and its intermediate. W0 2006136087.(本专利属于Nhwa Pharma Corporation, Peop Rep China) |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11877 |
Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate
|
105-56-6 |
C5H7NO2 |
详情 | 详情
|
(II) |
26052 |
3-methylbutanal
|
590-86-3 |
C5H10O |
详情 | 详情
|
(III) |
66601 |
diethyl 3-isobutylpentanedioate |
|
C13H24O4 |
详情 | 详情
|
(IV) |
26065 |
3-isobutylpentanedioic acid
|
|
C9H16O4 |
详情 |
详情
|
(V) |
66602 |
4-isobutylpiperidine-2,6-dione |
|
C9H15NO2 |
详情 | 详情
|
(VI) |
26056 |
3-(aminomethyl)-5-methylhexanoic acid
|
130912-52-6 |
C8H17NO2 |
详情 | 详情
|